# Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment

> **NCT05642806** · PHASE4 · UNKNOWN · sponsor: **St. Paul's Sinus Centre** · enrollment: 90 (estimated)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps
- Asthma
- Chronic Rhinosinusitis Without Nasal Polyps

## Interventions

- **BIOLOGICAL:** Mepolizumab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05642806
- **Lead sponsor:** St. Paul's Sinus Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-01
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05642806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05642806, "Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05642806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*